<DOC>
	<DOCNO>NCT01543269</DOCNO>
	<brief_summary>This clinical study evaluate safety , tolerability pharmacokinetics ZYT1 , follow oral administration healthy volunteer . The study shall divide four plan give : 1 . Plan I : Single dose escalation trial 2 . Plan II : Multiple dose escalation trial 3 . Plan III : Food effect trial . 4 . Plan IV : Gender Effect trial . The safety tolerability shall evaluate use physical examination , Standard laboratory test ( hematology , biochemistry urine examination ) , electrocardiogram ( ECG ) thyroid scan . Spontaneously report solicited adverse event also use safety parameter .</brief_summary>
	<brief_title>A Clinical Study Evaluate Safety , Tolerability PK ZYT1 , Following Oral Administration Healthy Volunteers</brief_title>
	<detailed_description>This clinical study evaluate safety , tolerability pharmacokinetics ZYT1 , follow oral administration healthy volunteer . The study divide four plan give : 1 . Plan I : Single dose escalation trial : A study evaluate safety , tolerability PK ZYT1 healthy volunteer . 2 . Plan II : Multiple dose escalation trial : A study evaluate safety , tolerability , PK , demonstrate , capture Pharmacodynamics ZYT1 healthy volunteer . 3 . Plan III : Food effect trial Effect food pharmacokinetics study cross study , select dose base limit detection investigational medicinal product ( IMP ) analytical method . 4 . Plan IV : Gender Effect trial . The gender effect study conduct completion Panel S5 single dose safety tolerability study The safety tolerability shall evaluate use physical examination , Standard laboratory test ( hematology , biochemistry urine examination ) , electrocardiogram ( ECG ) thyroid scan . Spontaneously report solicited adverse event also use safety parameter .</detailed_description>
	<mesh_term>Lipid Metabolism Disorders</mesh_term>
	<criteria>1 . Age : 1845 year 2 . Mentally , physically legally eligible give inform consent . 3 . Male female volunteer weigh 5075kg 4575kg respectively . 4 . Ability communicate effectively study personnel . 5 . Willingness adhere protocol requirement . 6 . Normal Thyroid Function Tests ( free total T3 , free total T4 TSH ) 7 . Lipid criterion : Low density lipoprotein ( LDL ) cholesterol 160mg/dL triglyceride ( TG ) level 500mg/dL 8 . For gender effect study , females history sterility one year menopause use long acting nonhormonal contraceptive measure ( e.g. , Intra uterine device ) recruit . 1 . Presence history hypersensitivity active inactive ingredient ZYT1 formulation . 2 . History thyroid disorder ( form ) within 24 week prior recruitment study . 3 . Active liver disease and/or liver transaminases great 1.5 X upper limit normal ( ULN ) . 4 . Renal insufficiency ( serum creatinine &gt; 1.5mg/dL ) . 5 . History myocarditis , hypertrophic cardiomyopathy , valvular heart disease , restrictive cardiomyopathy , constrictive pericarditis , myocardial infarction , ischemic heart disease , stroke , congestive heart failure , cardiac arrhythmia coronary revascularization procedure time . 6 . Subject correct QT interval ( QTc ) Â³ 450 ( male ) 470 ( female ) . 7 . History presence musculoskeletal disorder ( e.g. , myopathy , myolysis , fracture due osteoporosis , etc . ) 8 . History presence systemic disorder disease ( e.g. , respiratory , gastrointestinal , endocrine , immunological , dermatological , neurological , psychiatric disease body system involvement ) . 9 . Subjects take hormonal therapy e.g. , glucocorticoid , androgens growth hormone . 10 . Use thyroid supplement ( levothyroxine , liothyronine , etc . ) preparation contain thyromimetic agent within 24 week prior study entry . 11 . History coagulopathy use anticoagulant warfarin . 12 . History presence chronic medication medication last 14 day . 13 . History presence significant alcoholism drug abuse within past oneyear . 14 . History presence significant smoking ( 10 cigarette per day ) consumption tobacco product ( 10 time per day ) . 15 . Difficulty donate blood . 16 . Systolic blood pressure 140 mmHg less 100 mmHg diastolic blood pressure 90 mmHg less 60 mmHg . 17 . Pulse rate le 60/minute 100/minute . 18 . Any clinically significant abnormal Xray laboratory finding screen . 19 . History presence clinically significant ECG abnormality screen . 20 . Major illness and/or Major surgery last 3 month . 21 . Volunteers participate drug research study present trial within past 3 month . 22 . Volunteers donate one unit ( 350ml ) blood past 3 month . 23 . For gender effect study , female volunteer follow criterion recruit : History pregnancy lactation past 3 month b Fertile female volunteer protect pregnancy adequate longterm anti fertility device history less one year menopause Using hormonal contraceptive Using hormone replacement therapy Unable give assurance protection pregnancy 3 month participation trial History osteoporosis history fracture past 6 month Positive urine pregnancy test day checkin .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Obesity</keyword>
	<keyword>Lipid disorder</keyword>
</DOC>